Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Guidelines for Writing Outcome

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...

Methods of Documentation III: PIE

Methods of Documentation III: PIE

Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Patient-centered Care

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...

Methods of Documentation II: POMR

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.

Introduction To Health Care Delivery System

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Motivational Interviewing: A Physician and Social Worker Partnership in Rehabilitation Healthcare.

Health & social work·2024

Same author

Social Work and Engaging with the Seemingly Incompatible Host Agency.

Health & social work·2022

Same author

Lower Copays Sweeten Outcomes-based Deal for Brilinta.

Managed care (Langhorne, Pa.)·2019

Same author

Once-a-day HIV Treatment: Pricey But Perhaps Worth It.

Managed care (Langhorne, Pa.)·2019

Same author

CVS and the $100,000 QALY.

Managed care (Langhorne, Pa.)·2019

Same author

Backlash Against Copay Accumulators.

Managed care (Langhorne, Pa.)·2018

Search research articles

Related Experiment Video

Updated: May 14, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

… what do payers really want to see?

Ed Silverman

Biotechnology Healthcare

|February 2, 2013

Summary

The launch of a lower-cost monoclonal antibody for colorectal cancer may not signal a price war. Payers often remain skeptical of lower prices for biologic drugs, even with rising healthcare costs.

Area of Science:

Oncology
Pharmacoeconomics
Biotechnology

Background:

The introduction of lower-priced biologic drugs, such as monoclonal antibodies, is becoming more common in the pharmaceutical market.
Colorectal cancer treatment landscape includes high-cost biologic therapies, prompting market analysis of pricing strategies.
Payers (e.g., insurance companies, healthcare systems) play a critical role in drug adoption and reimbursement, often influenced by factors beyond price.

Purpose of the Study:

To analyze the potential impact of a lower-priced monoclonal antibody for colorectal cancer on the pharmaceutical market.
To evaluate payer perspectives on biologic drug pricing, particularly in the context of cost-saving alternatives.
To determine if the launch signifies a broader price war within the biotechnology industry.

More Related Videos

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

Related Experiment Videos

Last Updated: May 14, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

Main Methods:

Market analysis of drug pricing trends in the oncology sector.
Review of payer decision-making criteria for biologic drug adoption.
Assessment of the competitive landscape for colorectal cancer therapies.

Main Results:

The launch of a lower-priced monoclonal antibody for colorectal cancer does not necessarily indicate an industry-wide price war.
Payers exhibit skepticism towards lower-priced biologics, suggesting price alone may not be a decisive factor in market penetration.
Factors beyond initial cost, such as long-term efficacy and value, influence payer acceptance.

Conclusions:

The market dynamics for biologic drugs are complex and not solely driven by price reductions.
Payer skepticism necessitates a comprehensive value proposition for lower-cost biologics to achieve market success.
Further investigation into payer criteria and real-world evidence is needed to understand the long-term impact on drug pricing and access.